- 4-Week # shares sold: 7,500
- 12-Week # shares sold: 7,500
- 24-Week # shares sold: 488,076
Biogen spinoff Bioverativ proved healthy out of the gate, jumping from an open of $40 a share to a close of $47.35.
President-elect Donald Trump said the pharma industry was 'getting away with murder' during his first press conference as president-elect.